The MOBILE Study—A Phase IIa Enriched Enrollment Randomized Withdrawal Trial to Assess the Analgesic Efficacy and Safety of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Patients with Peripheral Neuropathic Pain

OBJECTIVE: To evaluate the analgesic efficacy and safety of ASP8477 in patients with peripheral neuropathic pain (PNP). DESIGN: Enriched enrollment randomized withdrawal. SETTING: Centers in Poland (four), Czech Republic (six), and the United Kingdom (two). SUBJECTS: Patients aged 18 years or older...

Descripción completa

Detalles Bibliográficos
Autores principales: Bradford, Daniel, Stirling, Anjali, Ernault, Etienne, Liosatos, Maggie, Tracy, Katherine, Moseley, Jennifer, Blahunka, Paul, Smith, Mike D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
METHODOLOGY, MECHANISMS & TRANSLATIONAL RESEARCH SECTION
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5939857/
https://www.ncbi.nlm.nih.gov/pubmed/28383710
http://dx.doi.org/10.1093/pm/pnx046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5939857/
https://www.ncbi.nlm.nih.gov/pubmed/28383710
http://dx.doi.org/10.1093/pm/pnx046

Ejemplares similares